Characterization of an immortalized cell line from a patient with epidermolytic hyperkeratosis

Journal of Investigative Dermatology

Volumn 106, Issue 3, 1996, Pages 385-390

  Chipev, Constantin C ^a   Steinert, Peter M ^a   Woodworth, Craig D ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Arg to His mutation; Immunohistochemistry; Keratin 10; RT PCR allele specific assay; Submerged and organotypic cultures

Indexed keywords

FILAGGRIN; KERATIN;

ADULT; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; HYPERKERATOSIS; MOLECULAR BIOLOGY; MUTATION; PRIORITY JOURNAL;

EID: 0029921529     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12343322     Document Type: Article

References (23)

1. Cheng J, Syder AJ, Yu QC, Letai A, Paller AS, Fuchs E: The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 70:811-819, 1992
2. Chipev CC, Korge BP, Markova NG, Bale SJ, DiGiovanna JJ, Compton JG, Steinert PM: A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 70:821-828, 1992
3. Chipev CC, Yang JM, DiGiovanna JJ, Steinert PM, Marekov L, Compton JG, Bale SJ: Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet 54:179-190, 1994
4. Fenjves ES: Approaches to gene transfer in keratinocytes. J Invest Dermatol 103:70S-75S, 1994
5. DiGiovanna JJ, Bale SJ: Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 130:1026-1035, 1994
6. Fuchs E, Esteves RA, Coloumbe PA: Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci U S A 89:6906-6910, 1992
7. Fuchs E, Coloumbe P, Cheng J, Chan Y-M, Hutton E, Syder A, Degenstein L, Yu Q-C, Letai A, Vassar R: Genetic bases of epidermolysis bullosa simplex and epidermolytic hyperkeratosis. J Invest Dermatol 103:25S-30S, 1994
8. Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function and diseases. Annu Rev Biochem 63:345-382, 1994
9. Huber M, Scaletta C, Benathan M, Frenk E, Greenhalgh DA, Rothnagel JA, Roop DR, Hohl D: Abnormal keratin 1 and 10 cytoskeleton in cultured keratinocytes from epidermolytic hyperkeratosis caused by keratin 10 mutations. J Invest Dermatol 102:691-694, 1994
10. Ishida-Yamamoto A, McGrath JA, Judge MR, Leigh IM, Lane EB, Eady RAJ: Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis. J Invest Dermatol 99:19-26, 1992
11. Johnson LD, Idler WW, Zhou XM, Roop DR, Steinert PM: The structure of the gene for the human epidermal keratin of 67000 molecular weight. Proc Natl Acad Sci U S A 82:1896-1900, 1985
12. McCance DJ, Kopan R, Fuchs E, Laimins LA: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci U S A 85:7169-7173, 1988
13. McLean WHI, Eady RAJ, Dopping-Hepenstal PJC, McMillan JR, Leigh IM, Navsaria HA, Higgins C, Harper JI, Paige DG, Morley SM, Lane EB: Mutations in the 1A rod domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). J Invest Dermatol 102:24-30, 1994
14. Poumay Y, Pittelkow MR: Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J Invest Dermatol 104:271-276, 1995
15. Rieger M, Franke WW: Identification of an orthologous mammalian cytokerain gene. J Mol Biol 204:841-856, 1988
16. Roop DR, Cheng CK, Titterington L, Meyers CA, Stanley JR, Steinert PM, Yuspa SH: Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem 259:8037-8043, 1984
17. Rothnagel JA, Roop DR: Analysis, diagnosis and molecular genetics of keratin disorder. Curr Opin Dermatol 2:211-218, 1995
18. Rothnagel JA, Dominey AM, Dempsey LD, Longley MA, Greenhalgh DA, Gagne TA, Huber M, Frenk E, Hohl D, Roop D: Mutations in the rod domains of keratin 1 and 10 in epidermolytic hyperkeratosis. Science 257:1128-11302, 1992
19. Rothnagel JA, Greenhalgh DA, Wang XJ, Sellheyer K, Bickenbach JR, Dominey AM, Roop DR: Transgenic models of skin diseases. Arch Dermatol 129:1430-1436, 1993
20. Steinert PM, Bale SJ: Genetic skin diseases caused by mutations in keratin intermediate filaments. Trends Genet 9:280-284, 1993
21. Sullivan SM: Development of ribozymes for gene therapy. J Invest Dermatol 103:85S-89S, 1994
22. Woodworth CD, Cheng S, Simpson S, Hamacher L, Chow LT, Broker TR, DiPaolo JA: Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene 7:619-626, 1992
23. Yang JM, Chipev CC, DiGiovanna JJ, Bale SJ, Marekov LN, Steinert PM, Compton JG: Mutations in the keratin 1 gene in epidermolytic hyperkeratosis: Systematic structural basis for the occurrence of keratin mutations in genodermatoses. J Invest Dermatol 102:17-23, 1994